Global Acne Treatment Market: (2017-2021 Edition)

May 2017 | 56 pages | ID: GD64A441F2FEN
Daedal Research

Abstracts

Scope of the Report

The report entitled “Global Acne Treatment Market: (2017-2021 Edition)”, provides analysis of the global acne treatment market and its products, with detailed analysis of market size and growth in terms of value. The report also provides in brief about the market split. The global acne treatment market can be divided into seven segments: Antibiotics, Non-Inflammatory, Antimicrobials, Combination Medications, Hormonal Agents, Oral Retinoid, and Topical Retinoid.

The report also provides a detailed analysis of prescription drugs available in the market for acne treatment. Details of SOLODYN, EPIDUO, ABSORICA, ACZONE and DORYX has provided in terms of their worldwide sales.

The report includes the detailed regional analysis, covering market size and growth for global acne treatment market for the following regions: the US and Asia Pacific. The US is the largest market for acne treatment in terms of value.

Growth of the overall global acne treatment market has also been forecasted for the period 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

The global acne treatment market is highly fragmented with a large number of niche players. Company profiling of Foamix Pharmaceuticals Ltd., Valeant Pharmaceuticals, Dermira and Allergan (Actavis Plc) has provided in the report. Company profiling is based on attributes like business overview, financial overview and strategies adopted by these companies in order to grow in the market.

Country Coverage

• The US
• Asia Pacific

Company Coverage

• Foamix Pharmaceuticals Ltd.
• Valeant Pharmaceuticals
• Dermira
• Allergan (Actavis Plc)

Executive Summary

The global acne treatment market is growing rapidly over the years and is expected to increase further in the forecasted period (2017-2021). Global acne treatment is supported by a number of growth drivers such as rising disposable income, high global prevalence rate of acne, unhealthy eating habits and increasing awareness in teenagers regarding acne treatment etc. Yet, there are certain challenges such as entry of generic drugs, safety issue regarding products and increasing acceptance of ant-acne treatment etc. that hinder the growth of the market.

There are some latest trends that will help the market to grow in the forecasted period. Such trends are laser treatment, shift towards combination products, technology-driven products and efficacy concern on current drugs.

Contents

1. EXECUTIVE SUMMARY

2. INTRODUCTION

2.1 Overview of Acne
  2.1.1 Causes of Acne Vulgaris
2.2 Types of Acne
Acne Rosacea
Acne Cosmetica
Acne Fulminans
Acne Keloidalis Nuchae
Acne Chloracne
Acne Medicamentosa
2.3 Acne Treatment

3. GLOBAL MARKET ANALYSIS

3.1 Global Acne Treatment Market: An Analysis
  3.1.1 Global Dermatology Market
  3.1.2 Global Acne Treatment Market by Value
3.2 Global Acne Market Split

4. PRODUCT ANALYSIS

4.1 Global Prescription Drugs
  4.1.1 SOLODYN (Minocycline Hydrochloride)
  4.1.2 EPIDUO (Adapalene 0.1%, Benzoyl Peroxide 2.5%)
  4.1.3 DORYX (Doxycycline Heclate)
  4.1.4 ABSORICA/EPURIS
  4.1.5 ACZONE
4.2 Over the Counter Products

5. COUNTRY/REGIONAL ANALYSIS

5.1 The US Acne Treatment Market: An Analysis
  5.1.1 The US Acne Treatment Market by Value
  5.1.2 The US Acne Treatment Market by Segment
5.2 Asia Pacific Acne Treatment Market: An Analysis
  5.2.1 Asia Pacific Acne Treatment Market by Value

6. COMPETITIVE LANDSCAPE

6.1 Dermatology Company Valuations

7. COMPANY PROFILING

7.1 Foamix Pharmaceuticals Ltd.
  7.1.1 Business Overview
  7.1.2 Financial Overview
7.2 Valeant Pharmaceuticals
  7.2.1 Business Overview
  7.2.2 Financial Overview
7.3 Dermira
  7.3.1 Business Overview
  7.3.2 Financial Overview
7.4 Allergan (Actavis Plc.)
  7.4.1 Business Overview
  7.4.2 Financial Overview

List Of Figures

LIST OF FIGURES

Figure 1: Cause of Acne Vulgaris
Figure 2: Types of Acne
Figure 3: Acne Treatment Paradigms
Figure 4: Global Dermatology Market by Value; 2015-2016 (US$ Billion)
Figure 5: Global Dermatology Market by Value; 2017-2021 (US$ Billion)
Figure 6: Global Acne Treatment Market by Value; 2014-2016 (US$ Billion)
Figure 7: Global Acne Treatment Market by Value; 2017-2021 (US$ Billion)
Figure 8: Acne Treatment Market Split
Figure 9: Penetration of Total Solodyn vs. Generic Minocycline; 2014-2021
Figure 10: SOLODYN Global Sales; 2010-2016 (US$ Million)
Figure 11: EPIDUO Global Sales; 2014-2016 (US$ Million)
Figure 12: DORYX Global Sales; 2014-2016 (US$ Million)
Figure 13: ABSORICA Revenue Share; 2015
Figure 14: ABSORICA Global Sales; 2015-2021 (US$ Million)
Figure 15: ACZONE Global Sales; 2014-2016 (US$ Million)
Figure 16: US Acne Treatment Market by Value; 2014-2016 (US$ Billion)
Figure 17: US Acne Treatment Market by Value; 2017-2021 (US$ Billion)
Figure 18: Asia Pacific Acne Treatment Market by Value; 2012-2016 (US$ Million)
Figure 19: Asia Pacific Acne Treatment Market by Value; 2017-2021; (US$ Million)
Figure 20: Foamix Pharmaceuticals Ltd. Revenue; 2012-2016 (US$ Million)
Figure 21: Foamix Pharmaceuticals Ltd. Revenue by Region; 2016
Figure 22: Valeant Pharmaceuticals Revenue; 2012-2016 (US$ Billion)
Figure 23: Valeant Revenue by Products; 2016
Figure 24: Dermira Revenue; 2014-2016 (US$ Million)
Figure 25: Dermira Revenue by Segments; 2016
Figure 26: Dermira Research and Development; 2012-2016 (US$ Million)
Figure 2: Actavis Plc. Revenue; 2012-2016 (US$ Billion)
Figure 28: Actavis Plc Revenue Segmentation; 2016
Table 1: Common Topical OTC Products for Acne Treatment
Table 2: Dermatology Company Valuations; 2015
Table 3: Valeant Product Launches; 2014
Table 4: Important Dermira Product Categories
Table 5: Actavis Specialty Brands Research and Development